|
|
|
|
R&D plays a key role in Lesvi and Inke strategic objectives, for that reason the investments and expenditure on R&D account for 10% of sales revenue.
Our R&D strategy is mainly focused on design and development of active pharmaceutical ingredients (API), development and registration of generic pharmaceutical specialties as well as regulatory and technical support to our customers.
To achieve these goals R&D of Lesvi and Inke team is composed by more than 50 highly skilled specialists, and in addition a panel of renowned scientists and prestigious Academic Institutions also collaborate with our researchers to increase the value of our projects through innovation, quality and service.At present, 58 researchers form our R&D staff, 37 of which holding university degrees: 25 graduates and 12 PhD's.
None of the products will be supplied to countries in which this could be in conflict with the existing patents. However, the final responsibility lies exclusively with the buyer.
© All rights reserved. Invent Farma Group.
© All rights reserved. Invent Farma Group.
Presentation